Agfa completes Sterling purchase
Agfa completes Sterling purchaseAgfa's acquisition of Sterling Diagnostic Imaging is now complete. The Ridgefield Park, NJ-based film and PACS vendor has acquired all the capital stock of Sterling's parent company, SDI Holding Corp. A management
Agfa completes Sterling purchase
Agfa's acquisition of Sterling Diagnostic Imaging is now complete. The Ridgefield Park, NJ-based film and PACS vendor has acquired all the capital stock of Sterling's parent company, SDI Holding Corp. A management team for the combined companies has also been named. John Glass, managing director for Agfa-Gevaert's medical imaging business group, will head the combined businesses worldwide. Sterling executive vice president and COO Ernest Waaser will assume responsibilities previously held by Glass at Agfa, while Sterling chairman and CEO Rodney Wolford will stay on for a limited time to assist Glass and Waaser during the transition.
In other Agfa news, the firm's MIL-PACS organization will install PACS technology at a U.S. Naval Branch Medical Clinic in Key West, FL. The system will allow technicians in Key West to transmit digitized x-ray images to radiologists at the U.S. Naval Hospital in Jacksonville, FL. System delivery is slated for early August, with installation targeted for completion by late September.
The company has also received a $25 million contract from Queensland Health of Australia, which will use the firm's Impax offering to link the imaging units at five tertiary teaching hospitals. Agfa will serve as a systems integrator, linking Impax with four other major digital technology suppliers. Queensland Health hopes to convert to a totally filmless environment within two to three years, according to Agfa.
- Search again
- Homepage
ASCO: Study Reveals Significant Racial/Ethnic Disparities with PSMA PET Use for Patients with mPCa
May 30th 2025Latinx patients with metastatic prostate cancer were 63 percent less likely than non-Hispanic White patients to have PSMA PET scans, according to a study of 550 patients presented at the American Society of Clinical Oncology (ASCO) conference.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.
New MRI Study Questions Use of Corticosteroid Injections for Knee OA
May 27th 2025Two years after intraarticular knee injections for knee osteoarthritis (OA), study participants who had corticosteroid knee injections had greater OA progression than control patients while the use of hyaluronic acid injections was associated with less OA progression.
